Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Use of Naldemedine on Opioid-Induced Nausea and Vomiting in Patients With Cancer
NCT07038551Phase 4Completed
- Sponsor
- International University of Health and Welfare
- Start
- Jun 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naldemedine in Opioid-induced nausea and vomiting (OINV), sponsored by International University of Health and Welfare. Started Jun 2025; status: completed.
02
Drugs
naldemedine
03
Conditions
Opioid-induced nausea and vomiting (OINV)
Beyond the preview
Go deeper on NCT07038551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07038551.